top of page
Search

Market Watch: Penny Stocks to Look at This Week

Here are some good penny stocks to look at this week, along with their financial data, recent press, and new products:


Aemetis Inc. (AMTX)

  • Price: $0.75 per share

  • Market cap: $150 million

  • Revenue: $12.6 million (2021)

  • Net income: ($25.1 million) (2021)

  • Recent press: Aemetis announced that it has signed a definitive agreement to acquire Renewable Energy Group Inc. (REG), a leading renewable fuels company, for $610 million in cash and stock. The acquisition is expected to close in the second half of 2023.

  • New products: Aemetis is developing a new line of sustainable aviation fuel (SAF) products that are made from renewable feedstocks. The company is also developing a new line of renewable diesel products that are made from recycled cooking oil.

American Manganese Inc. (AMEX)

  • Price: $0.20 per share

  • Market cap: $100 million

  • Revenue: $1.2 million (2021)

  • Net income: ($10.1 million) (2021)

  • Recent press: American Manganese announced that it has signed a memorandum of understanding (MOU) with Piedmont Lithium Inc. (PLL) to explore the development of a lithium-ion battery cathode materials plant in North Carolina. The plant is expected to have a capacity of 100,000 tons per year and could create up to 1,000 jobs.

  • New products: American Manganese is developing a new lithium-ion battery cathode material called NMC-811. NMC-811 is a high-performance cathode material that is made from nickel, manganese, and cobalt.

BioSig Technologies Inc. (BSGM)

  • Price: $0.25 per share

  • Market cap: $100 million

  • Revenue: $0.1 million (2021)

  • Net income: ($1.7 million) (2021)

  • Recent press: BioSig Technologies announced that it has received CE Mark for its BioSig CoreQ+ ECG system. The BioSig CoreQ+ ECG system is a non-invasive, wearable device that can be used to monitor patients in a variety of settings, including hospitals, clinics, and home health care.

  • New products: BioSig Technologies is developing a new product called the BioSig CoreQ+ Heart Rate Monitor. The BioSig CoreQ+ Heart Rate Monitor is a wearable device that can be used to monitor patients' heart rates in real time.

Canntab Therapeutics Ltd. (CNAB)

  • Price: $0.20 per share

  • Market cap: $50 million

  • Revenue: $0.1 million (2021)

  • Net income: ($1.2 million) (2021)

  • Recent press: Canntab Therapeutics announced that it has received a Health Canada licence to sell its first cannabinoid-based prescription drug, Canntab CBD Oral Film. Canntab CBD Oral Film is a fast-acting, dissolvable film that is used to treat chronic pain.

  • New products: Canntab Therapeutics is developing a new product called Canntab THC Oral Film. Canntab THC Oral Film is a fast-acting, dissolvable film that is used to treat nausea and vomiting associated with chemotherapy.

Cellectar Biosciences Inc. (CLRB)

  • Price: $0.15 per share

  • Market cap: $25 million

  • Revenue: $0.0 million (2021)

  • Net income: ($10.2 million) (2021)

  • Recent press: Cellectar Biosciences announced that it has received a $3 million grant from the National Institutes of Health (NIH) to support the development of its lead drug candidate, CLR01, for the treatment of acute myeloid leukemia (AML). CLR01 is a cell-based cancer therapy that uses the patient's own white blood cells to deliver a targeted cancer drug to leukemia cells.

  • New products: Cellectar Biosciences is developing a new product called CLR02. CLR02 is a cell-based cancer therapy that uses the patient's own white blood cells to deliver a targeted cancer drug to lymphoma cells.

Please note that these are just a few examples of penny stocks that you may want to consider. It is important to do your own research before investing in any penny stock, as they are inherently risky investments.

By considering the factors listed above, you can increase your chances of making a successful investment in a penny stock.


4 views0 comments
Post: Blog2_Post
bottom of page